Cargando…

Model‐informed precision dosing of vancomycin for rapid achievement of target area under the concentration‐time curve: A simulation study

In this study, we aimed to evaluate limited sampling strategies for achieving the therapeutic ranges of the area under the concentration‐time curve (AUC) of vancomycin on the first and second day (AUC(0–24), AUC(24–48), respectively) of therapy. A virtual population of 1000 individuals was created u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oda, Kazutaka, Yamada, Tomoyuki, Matsumoto, Kazuaki, Hanai, Yuki, Ueda, Takashi, Samura, Masaru, Shigemi, Akari, Jono, Hirofumi, Saito, Hideyuki, Kimura, Toshimi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651648/ https://www.ncbi.nlm.nih.gov/pubmed/37718491 http://dx.doi.org/10.1111/cts.13626

Ejemplares similares

Model‐informed precision dosing of teicoplanin for the rapid achievement of the target area under the concentration‐time curve: A simulation study
por: Oda, Kazutaka, et al.
Publicado: (2023)

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
por: Matsumoto, Kazuaki, et al.
Publicado: (2022)

Validation of Vancomycin Area under the Concentration—Time Curve Estimation by the Bayesian Approach Using One-Point Samples for Predicting Clinical Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Infections
por: Ueda, Takashi, et al.
Publicado: (2022)

Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study
por: Oda, Kazutaka, et al.
Publicado: (2021)

The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing
por: Tsutsuura, Moeko, et al.
Publicado: (2021)

Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
por: Samura, Masaru, et al.
Publicado: (2022)

Continuous high-dose infusion of doripenem in a pneumonia patient infected by carbapenem-resistant Pseudomonas aeruginosa: a case report
por: Oda, Kazutaka, et al.
Publicado: (2019)

Simulation of Vancomycin Exposure Using Trough and Peak Levels Achieves the Target Area under the Steady-State Concentration–Time Curve in ICU Patients
por: Ibe, Yuta, et al.
Publicado: (2023)

Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis
por: Hanai, Yuki, et al.
Publicado: (2021)

Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
por: Hanai, Yuki, et al.
Publicado: (2022)

Clinical evaluation of an authorized medical equipment based on high performance liquid chromatography for measurement of serum voriconazole concentration
por: Oda, Kazutaka, et al.
Publicado: (2021)

1329. Vancomycin Therapeutic Drug Monitoring: How to hit the Curve
por: Vala, Michael, et al.
Publicado: (2020)

Vancomycin area under the curve-guided monitoring in pediatric patients
por: Morales Junior, Ronaldo, et al.
Publicado: (2022)

A novel step‐down infusion method of barbiturate therapy: Its safety and effectiveness for intracranial pressure control
por: Yamakawa, Yukako, et al.
Publicado: (2021)

Model-informed precision dosing in vancomycin treatment
por: Yoon, Sukyong, et al.
Publicado: (2023)

Concentration-Dependent Activity of Pazufloxacin against Pseudomonas aeruginosa: An In Vivo Pharmacokinetic/Pharmacodynamic Study
por: Umezaki, Yasuhiro, et al.
Publicado: (2022)

Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis
por: Fujimoto, Yuki, et al.
Publicado: (2021)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

1537. Multicenter Study with Therapeutic Drug Monitoring (TDM) of Voriconazole (VRCZ) in Japanese Patients
por: Ueda, Takashi, et al.
Publicado: (2019)

Assessing the appropriateness of the Moving Epidemic Method and WHO Average Curve Method for the syndromic surveillance of acute respiratory infection in Mauritius
por: Teeluck, Mohabeer, et al.
Publicado: (2021)

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
por: Matsumoto, Kazuaki, et al.
Publicado: (2016)

1571. Evaluation of a Single Post First Dose Vancomycin Level to Achieve a Goal Vancomycin AUC
por: Hurley, Evan, et al.
Publicado: (2019)

Clinical significance of polyglutamylation in primary central nervous system lymphoma
por: Shinojima, Naoki, et al.
Publicado: (2018)

Robotic-arm assisted THA can achieve precise cup positioning in developmental dysplasia of the hip: a case control study
por: Hayashi, Shinya, et al.
Publicado: (2021)

Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan
por: Hamada, Yukihiro, et al.
Publicado: (2020)

Vancomycin area under the curves estimated with pharmacokinetic equations using trough‐only data
por: Fewel, Nathan
Publicado: (2021)

67. Agreement Among Bayesian Dosing Software for Calculating Vancomycin Area Under the Curve
por: Pineda, Ross, et al.
Publicado: (2021)

1645. Predicting Vancomycin Area Under the Curve by Bayesian-Guided Dosing in Pediatric Patients
por: Shin, Donghyun, et al.
Publicado: (2023)

Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
por: Wesner, Amber R., et al.
Publicado: (2013)

Optimizing Vancomycin Therapy in Critically Ill Children: A Population Pharmacokinetics Study to Inform Vancomycin Area under the Curve Estimation Using Novel Biomarkers
por: Downes, Kevin J., et al.
Publicado: (2023)

Underestimation of the Calculated Area Under the Concentration-Time Curve Based on Serum Creatinine for Vancomycin Dosing
por: Jin, Sung Joon, et al.
Publicado: (2014)

1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
por: Weaver, Krista, et al.
Publicado: (2019)

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC)
por: Deng, Yutao, et al.
Publicado: (2023)

2567. Clinical Outcomes of Vancomycin Area-Under-the-Curve Monitoring: A Quasi-Experimental Study
por: Viteri, Alina, et al.
Publicado: (2023)

Suppressed Hepatic Production of Indoxyl Sulfate Attenuates Cisplatin-Induced Acute Kidney Injury in Sulfotransferase 1a1-Deficient Mice
por: Yabuuchi, Nozomi, et al.
Publicado: (2021)

Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients
por: Hodiamont, C J, et al.
Publicado: (2021)

Achievement of Vancomycin Therapeutic Goals in Critically Ill Patients: Early Individualization May Be Beneficial
por: Shahrami, Bita, et al.
Publicado: (2016)

Midkine: A Novel Prognostic Biomarker for Cancer
por: Jono, Hirofumi, et al.
Publicado: (2010)

Clinical evaluation of flat peripheral curve design with aspherical-curve and multi-curve hard contact lenses for keratoconus
por: Kumanomido, Takashi, et al.
Publicado: (2022)

192. The Use of Area Under the Curve to Determine Therapeutic Vancomycin Dosing in Skin and Soft Tissue Infections
por: Dea, Lauren, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h3p9fdpr2klnfqrdug73103ail